upcarta
  • Sign In
  • Sign Up
  • Explore
  • Search

Quantum AI Series: Dr. Hans Melo, CEO of Menten AI - Exclusive Interview by Maëva Ghonda

  • Podcast episode
  • Dec 28, 2021
  • #ArtificialIntelligence
Hans
@HansMelo1
(Host)
Menten AI
@menten_ai
(Guest)
open.spotify.com
Listen on Spotify
1 Recommender
1 Mention
The Quantum AI Series features exclusive interviews of the global innovators shaping the future of quantum computing. In Episode 4 of Season 2, Maëva Ghonda, the founder and chair o... Show More

The Quantum AI Series features exclusive interviews of the global innovators shaping the future of quantum computing. In Episode 4 of Season 2, Maëva Ghonda, the founder and chair of the Quantum AI Institute, interviews Dr. Hans Melo, CEO, Menten AI.

Dr. Hans Melo is co-founder and CEO of Menten AI, Inc., a therapeutics company and leader in quantum computing applications in drug discovery. He holds a PhD in Machine Learning and Computational Neuroscience from the University of Toronto.

Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We develop computational methods for protein design that leverage machine learning and quantum computing.

---

Send in a voice message: https://anchor.fm/quantum-ai-institute/message

Show Less
Recommend
Post
Save
Complete
Collect
Mentions
See All
Jeff Clavier @JeffClavier · Jan 9, 2022
  • Post
  • From Twitter
Interested in learning more about quantum computing applied to drug discovery? Listen to this podcast [link] featuring @HansMelo1 from @menten_ai, one of our portfolio companies. It's pretty awesome.
  • upcarta ©2025
  • Home
  • About
  • Terms
  • Privacy
  • Cookies
  • @upcarta